Roadshow
Instant NanoBiosensors (INB)
Instant NanoBiosensors (INB) is an innovative precision medicine company specializing in ultra-sensitive protein-based blood tests for Alzheimer’s disease and gene-based leukemia diagnostics through its INLab NGS Solution.
A. Alzheimer’s Disease: Ultra-Sensitive Blood Test
Using our proprietary FOPPR™ technology, INB offers a non-invasive, rapid, and cost-effective blood test for early Alzheimer’s detection. Our Light Sensing Biomarker Analyzer is the only POCT solution integrating antibody analysis to assay development, making it a key tool in the EU-funded Tau-ImMunE (TAME) project. By eliminating the complexity of traditional and current blood-based biomarker diagnostics , INB provides accessible and precise solutions for early detection and therapeutic monitoring.
B. Leukemia Precision Medicine: INLab NGS Solution
INB’s fully integrated NGS platform covers the entire workflow—from sample processing to final report generation. Adopted by National Taiwan University Hospital, our solution serves nearly 70% of leukemia patients in Taiwan.
INB’s fully integrated NGS platform covers the entire workflow—from sample processing to final report generation. Adopted by National Taiwan University Hospital, our solution serves nearly 70% of leukemia patients in Taiwan.
Key Advantages
✅ DimerOff™ Technology: Minimizes sequencing noise, improving MDS/AML mutation detection, reducing costs by 50%, and shortening turnaround time to 3 days.
✅ MRD & MPN Monitoring: Enables precise residual disease tracking for better patient management.
✅ Customizable NGS Panels: Tailored to clinical and research needs, optimizing diagnostics and reducing costs.
C. We Are Seeking Partners
🔹 Distributors, Biotech & Pharma companies for global expansion and co-development.
🔹 Hospitals & CROs looking to establish precision medicine solutions.
🔹 Scientists & Research Institutions interested in grant collaboration.
- Established 2016
- Company INSTANT NANOBIOSENSORS CO.,LTD
- Telephone +886-2-26538655
- Address Rm.C328, 3rd Floor, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist. Taipei City 11571, Taiwan
Instant NanoBiosensors focused mainly on the development of the Light-Sensing Protein & Nucleic Acid Biomarker Portable Platform that utilizes FOPPR (Fiber Optic Particle Plasmon Resonance) technology to revolutionize traditional immunoassays and analysis for a more efficient healthcare ecosystem. We believed that the integration of nanotechnology into biosensors will benefit the world by moving bioanalysis from laboratory to any point of use. The vision of our will be the pioneer and leader in portable biosensors platforms for protein and nucleic acid biomarkers in five years. In May 2019, we launched Light Sensing Biomarker Analyzer, which won its first overseas order from Brigham and Women's Hospital (BWH), a teaching hospital of Harvard Medical School and have been working with BWH in clinical studies. In 2020, we were one the 12 innovative young companies for worldwide strategic collaboration selected by Merck KGaA because of our unique fiber optic microfluidics nano-chip technology. As we can analyze -- with three easy steps -- proteins and nucleic acids like top laboratories, we hope through our system we can realize our dream of “immediate care” to make health care quicker, cheaper, and more comfortable without sacrificing quality.